Skip to main content
FinSpry Logo
FinSpry
TNGX logo
TNGX
(NASDAQ)
Tango Therapeutics, Inc.
$20.22-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tango Therapeutics (TNGX) Stock Price & Financial Analysis

Tango Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.43 - $22.16
52-Week High$28.41
52-Week Low$3.58
Open$22.02
Volume4.02M
Average Volume (3M)3.01M
Market Cap2.57B
Shares Outstanding116.17M
Price to Sales (P/S)41.25
Price to Book (P/B)7.43
EV/EBITDA-22.88
Revenue (TTM)62.38M
Net Income (TTM)-101.59M
Free Cash Flow (TTM)-139.93M
EPS (TTM)$-0.89
Profit Margin-162.85%
Operating Margin-178.39%
Return on Equity (ROE)-29.35%
Debt to Equity0.10
50-Day MA$22.47
200-Day MA$13.26
52-Week Change476.07%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tango Therapeutics

What is the current stock price for TNGX?

As of the latest trading session, TNGX stock trades at $20.22. The 52-week range is $3.58–$28.41, with a day range of $19.43–$22.16.

What is the P/E ratio for TNGX?

The P/E ratio (Price-to-Earnings) for TNGX is shown in the Key Statistics section. This valuation metric helps compare Tango Therapeutics, Inc. to industry peers.

Does TNGX pay dividends?

Tango Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TNGX?

Based on 3 analysts, the consensus for TNGX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TNGX?

Tango Therapeutics's market capitalization is $2.35B, classifying it as a mid-cap company. Tango Therapeutics operates in the Healthcare sector within the Biotechnology industry.